Performance of soluble suppressor of tumorigenicity-2 as a prognostic marker for severe dengue in adults

被引:0
|
作者
Teo, Andrew [1 ,2 ,3 ]
Chia, Po Ying [1 ,3 ,4 ]
Yeo, Tsin Wen [1 ,3 ,4 ]
机构
[1] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore
[2] Univ Melbourne, Doherty Inst, Dept Med, Melbourne, Vic, Australia
[3] Natl Ctr Infect Dis, Singapore, Singapore
[4] Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore
关键词
D O I
10.1016/j.jinf.2023.10.003
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:592 / 594
页数:3
相关论文
共 50 条
  • [21] The pro-inflammatory marker soluble suppression of tumorigenicity-2 (ST2) is reduced especially in diabetic morbidly obese patients undergoing bariatric surgery
    Demyanets, Svitlana
    Kaun, Christoph
    Kaider, Alexandra
    Speidl, Walter
    Prager, Manfred
    Oravec, Stanislav
    Hohensinner, Philipp
    Wojta, Johann
    Rega-Kaun, Gersina
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
  • [22] Diagnostic and prognostic value of serum soluble suppression of tumorigenicity-2 in heart failure with preserved ejection fraction: A systematic review and meta-analysis
    Shi, Yujiao
    Liu, Jiangang
    Liu, Chunqiu
    Shuang, Xiong
    Yang, Chenguang
    Qiao, Wenbo
    Dong, Guoju
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [23] Soluble Suppression of Tumorigenicity-2 (sst2) Predicts Mortality and Right Heart Failure in Lvad Patients
    Numan, L.
    Aarts, E.
    Ramjankhan, F.
    Van der Meer, M. G.
    Oerlemans, M.
    De Jonge, N.
    Oppelaar, A.
    Kemperman, H.
    Asselbergs, F.
    Van Laake, L. W.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S364 - S365
  • [24] The pro-inflammatory marker soluble suppression of tumorigenicity-2 (ST2) is reduced especially in diabetic morbidly obese patients undergoing bariatric surgery
    Svitlana Demyanets
    Christoph Kaun
    Alexandra Kaider
    Walter Speidl
    Manfred Prager
    Stanislav Oravec
    Philipp Hohensinner
    Johann Wojta
    Gersina Rega-Kaun
    Cardiovascular Diabetology, 19
  • [25] Soluble form of suppression of tumorigenicity-2 predicts clinical stability of inpatients with community-acquired pneumonia
    Zeng, Yifeng
    Xue, Mingshan
    Zhang, Teng
    Sun, Shixue
    Lin, Runpei
    Li, Ning
    Zheng, Peiyan
    Zhen, Yingjie
    Hu, Haisheng
    Zhang, Xiaohua Douglas
    Sun, Baoqing
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2021, 246 (21) : 2297 - 2306
  • [26] Soluble Interleukin-2 Receptor Level as a Marker of Hemophagocytic Lymphohistiocytosis in Children With Severe Dengue
    Singh, Dhirendra
    Raghunathan, Veena
    Dhaliwal, Maninder
    Rastogi, Neha
    Chadha, Ritu
    Yadav, Satya Prakash
    FRONTIERS IN PEDIATRICS, 2021, 9
  • [27] The Continuation of Trickle-Down Medicine: Soluble Suppression of Tumorigenicity-2 (sST2) in Pediatric Heart Failure
    Greenway, Steven C.
    CANADIAN JOURNAL OF CARDIOLOGY, 2019, 35 (06) : 692 - 693
  • [28] Soluble Suppression of Tumorigenicity-2 Predicts Mortality and Right Heart Failure in Patients With a Left Ventricular Assist Device
    Numan, Lieke
    Aarts, Emmeke
    Ramjankhan, Faiz
    Oerlemans, Marish I. F.
    van der Meer, Manon G.
    de Jonge, Nicolaas
    Oppelaar, Anne-Marie
    Kemperman, Hans
    Asselbergs, Folkert W.
    Van Laake, Linda W.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (02):
  • [29] Febrile Phase Soluble Urokinase Plasminogen Activator Receptor and Olfactomedin 4 as Prognostic Biomarkers for Severe Dengue in Adults
    Teo, Andrew
    Le, Chau Thuy Tien
    Tan, Trevor
    Chia, Po Ying
    Yeo, Tsin Wen
    CLINICAL INFECTIOUS DISEASES, 2024, 78 (03) : 788 - 796
  • [30] SOLUBLE SUPPRESSION OF TUMORIGENICITY-2 PREDICTS HOSPITAL MORTALITY IN BURN PATIENTS: AN OBSERVATIONAL PROSPECTIVE COHORT PILOT STUDY
    Ruiz-Castilla, Mireia
    Bosacoma, Pau
    Dos Santos, Bruce
    Baena, Jacinto
    Guilabert, Patricia
    Marin-Corral, Judith
    Masclans, Joan R.
    Roca, Oriol
    Barret, Juan P.
    SHOCK, 2019, 51 (02): : 194 - 199